ROCKWELL MEDICAL, INC. (RMTI) Net margin 2017–2025
ROCKWELL MEDICAL, INC. (RMTI) net profit margin by fiscal year — reported net income divided by reported revenue.
-7.7%FY2025 · since FY2017: -45.2% → -7.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7.7% | -7.2 pp |
| FY2024 | -0.5% | +9.6 pp |
| FY2023 | -10.1% | +15.6 pp |
| FY2022 | -25.7% | +27.1 pp |
| FY2021 | -52.8% | -3.1 pp |
| FY2020 | -49.7% | +6.0 pp |
| FY2019 | -55.7% | -5.0 pp |
| FY2018 | -50.7% | -5.4 pp |
| FY2017 | -45.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RMTI financial trends
RMTI RevenueRMTI Net incomeRMTI Gross profitRMTI Gross marginRMTI Operating incomeRMTI Operating marginRMTI Operating cash flowRMTI Free cash flowRMTI Capital expendituresRMTI Return on equityRMTI Stock buybacksRMTI Dividends paidRMTI Total assetsRMTI Total liabilitiesRMTI Shareholders’ equityRMTI overview →